Background: Prurigo nodularis is a chronic pruritic dermatosis and narrowband-UVB (NB-UVB) phototherapy is considered an effective and safe treatment option in patients with multiple comorbidities.

Prurigo nodularis is a skin condition that causes extremely itchy and symmetrical papulonodular lesions, usually on the extensor surfaces of the arms and legs. Its cause is still unknown, but it's ...

Nemolizumab was well tolerated and provided lasting relief from itching and disease severity while improving quality of life in patients with prurigo nodularis (PN) over 68 weeks. Patients also ...

ORLANDO, Fla. — The topical Janus tyrosine kinase (JAK) 1/2 inhibitor ruxolitinib improved itching and nodules in patients with prurigo nodularis (PN) significantly better than a vehicle within ...

Incyte INCY announced positive results from two late-stage studies evaluating the safety and efficacy of its twice-daily ruxolitinib cream 1.5% in adults with prurigo nodularis (PN). The data ...

The American Academy of Dermatology gratefully acknowledges the support from Sanofi and Regeneron. Where does prurigo nodularis develop on the body? Prurigo nodularis causes itchy bumps on the skin, ...

"These results show – for the first time in a Phase 3 prurigo nodularis trial – that a systemic medicine was able to address the most debilitating symptoms such as itch without broadly ...

If you have this skin condition, you know how itchy it can be. Prurigo nodularis is considered one of the itchiest skin conditions, if not the itchiest. Many people say that their skin itches severely ...